Navigation Links
TAXUS Express2 Monorail Paclitaxel-Eluting Coronary Stent System

ProductsTAXUS Express2 Monorail Paclitaxel-Eluting Coronary Stent System
Company Boston Scientific Corporation
Item TAXUS Express2 Monorail Paclitaxel-Eluting Coronary Stent System
Features A Proven Stent
The Express Stent platform offers excellent deliverability and conformability.
  • Excellent deliverability allows for treatment of a variety of patient and lesion types.
  • Excellent conformability allows the stent to mold to the natural contours of the vessel wall.
  • Broad working range facilitates precise deployment and sizing flexibility, making it easy to achieve full stent apposition.
  • A Reliable Polymer
    The TAXUS stent uses Translute Polymer, a proprietary polymer carrier technology, to control drug release.
  • he durable Translute Polymer protects the drug and maintains coating integrity during preparation, delivery, and stent expansion.
  • The polymer controls the release of paclitaxel, which may allow for consistent drug release and more uniform drug distribution.
  • An Effective Drug
    The unique properties of paclitaxel may contribute to the efficacy of the TAXUS Stent.
  • Paclitaxel's multi-functional effects, stabilize microtubules and inhibit activities that contribute to restenosis.
  • Paclitaxel is highly lipophilic, which may contribute to more uniform drug distribution.
  • At the dose used in the TA
  • Description The TAXUS Express Paclitaxel-Eluting Coronary Stent System is indicated for improving luminal diameter for the treatment of de novo lesions = 28 mm in length in native coronary arteries = 2.5 to = 3.75 mm in diameter.
    Info Boston Scientific Corporation
    Customer Service: (888) 272-1001
    Web site: http://www.bostonscientific.com

    Related medicine products :

    1. TAXUS Express2 Over-the-wire Paclitaxel-Eluting Coronary Stent System
    2. NIR Elite Monorail Stent System
    3. Cutting Balloon Ultra2 Monorail Platform
    4. Atlantis SR Pro Coronary Imaging Catheter
    5. Cypher Sirolimus-eluting Coronary Stent
    6. MULTI-LINK OTW PIXEL Coronary Stent System
    7. MULTI-LINK RX PIXEL Coronary Stent System
    8. Express Coronary Stent System
    9. S660 with Discrete Technology Coronary Stent System
    10. MULTI-LINK OTW ZETA Coronary Stent System
    11. MULTI-LINK OTW PENTA Coronary Stent System
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    Medicine Products:
    (Date:9/20/2017)... (PRWEB) , ... September 20, ... ... a software company specializing in medical device compliance and commercialization, has just ... risk management activities. , FDA is more adamant than ever about medical ...
    (Date:9/20/2017)... ... September 20, 2017 , ... Demand ... at the East-coast edition of MarTech: The Marketing Tech Conference October 2–4, at ... more than 40 speakers — representing such thought-leading companies as JP Morgan ...
    (Date:9/20/2017)... ... September 20, 2017 , ... ... and innovation, the company recently unveiled a redesigned website. The new site – ... work of building owners, architects, contractors and other industry users that Garland serves. ...
    (Date:9/20/2017)... ... September 20, 2017 , ... Each year Athletic ... National Athletic Trainers’ Association Annual Clinical Symposium and Expo. New research is revealed, ... when Athletic Trainers are acknowledged by their peers with accolades and highly prestigious ...
    (Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... digital and social campaign, “Humans With Vaginas.” The goal is to ignite conversation ... of non-toxic personal care products. The brand has declared September “Humans with Vaginas” ...
    Breaking Medicine News(10 mins):
    (Date:9/6/2017)... TORONTO , Sept. 6, 2017 /PRNewswire/ ... new knowledge and skills while treating their ... for hands-on experience without involving patients. Simulation ... skills. Clinicians can carry out procedures, refine ... at risk. Integration of new technology, such ...
    (Date:9/6/2017)... NeuroRx, a clinical stage biopharma company developing the first oral ... granted Fast Track status by the US Food and Drug ... by NRX-101 (D-cycloserine + lurasidone). The company will shortly begin ... targeting patients who are admitted to Emergency Departments with ASIB ... ...
    (Date:9/5/2017)... Colo. , Sept. 5, 2017 Sapheneia ... XR-29 DoseCheck solution. Scannerside DoseCheck is a third-party Vendor ... existing CT scanners and allows compliance with current MITA ... Sapheneia-Scannerside proprietary XR 29 DoseCheck solution is specifically designed ... and alerts of potential radiation doses over a predefined ...
    Breaking Medicine Technology: